New STAT report explores viral vectors, the linchpin of gene therapy
Gene therapy, once dismissed as too dangerous, has made a comeback, with two products approved in the U.S. since December…More
Gene therapy, once dismissed as too dangerous, has made a comeback, with two products approved in the U.S. since December…More
In March, AstraZeneca signed a deal with Japanese drugmaker Daiichi Sankyo that would pay up to $6.9 billion — $1.35…More
Poul and Else were married for 57 years. For the last four, their granddaughter, photographer Sofie Mathiassen, documented their life…More
NEW YORK — The U.S. winter flu season is off to its earliest start in more than 15 years. An…More
Tufts University announced Thursday it will strip the Sackler name from a graduate school, buildings, and health programs — one…More
The global emergency stockpile of Ebola vaccines will grow to 500,000 doses following a decision Thursday by the board of…More
Sue Desmond-Hellmannn is stepping down as CEO of the Bill and Melinda Gates Foundation, the world’s largest funder of biomedical…More
When Charlie Luckesen turned 2 the Wednesday before Thanksgiving, his family celebrated with a golden balloon nearly twice his height,…More
Police shootings of unarmed black Americans have escalated a national debate about racial injustice and the use of force. A…More
Birth control pills work great if women remember to take them every day, but missing doses can mean a surprise…More